Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Inv. presentation
Quarterly results

CHINOOK THERAPEUTICS, INC. (KDNY) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/21/2023 15-12G Form 15-12G - Securities registration termination [Section 12(g)]:
08/17/2023 EFFECT Form EFFECT - Notice of Effectiveness:
08/11/2023 SC 13D Farallon Capital Partners, L.P. reports a 9.9% stake in Chinook Therapeutics, Inc.
08/11/2023 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
08/11/2023 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
08/11/2023 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
08/11/2023 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
08/11/2023 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
08/11/2023 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
08/11/2023 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
08/11/2023 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
08/11/2023 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
08/11/2023 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
08/11/2023 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
08/11/2023 POSASR Form POSASR - Post-effective Amendment to an automatic shelf registration statement:
08/11/2023 POS AM Form POS AM - Post-Effective amendments for registration statement:
08/11/2023 8-K Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Fa...
Docs: "Amended and Restated Certificate of Incorporation",
"Amended and Restated Bylaws"
08/11/2023 4 Thomas Dolca (Director) has filed a Form 4 on CHINOOK THERAPEUTICS, INC.
Txns: Disposed/sold 13,300 shares @ $0
Disposed/sold 23,522 options to buy @ $14.77, valued at $347.4k
Disposed/sold 5,948 options to buy @ $16.81, valued at $100k
Disposed/sold 13,300 options to buy @ $13.88, valued at $184.6k
08/11/2023 4 Oxtoby Andrew (Chief Commercial Officer) has filed a Form 4 on CHINOOK THERAPEUTICS, INC.
Txns: Disposed/sold 160,000 options to buy @ $21.82, valued at $3.5M
Disposed/sold 40,000 restricted stock units @ $0
08/11/2023 4 Krishnan Mahesh (Director) has filed a Form 4 on CHINOOK THERAPEUTICS, INC.
Txns: Disposed/sold 1,275 shares @ $0
Disposed/sold 26,600 options to buy @ $16.74, valued at $445.3k
Disposed/sold 4,401 restricted stock units @ $0
08/11/2023 4 King Andrew James (Chief Scientific Officer) has filed a Form 4 on CHINOOK THERAPEUTICS, INC.
Txns: Disposed/sold 19,157 shares @ $0
Disposed/sold 43,047 options to buy @ $0.35, valued at $15.1k
Disposed/sold 73,047 options to buy @ $0.42, valued at $30.7k
Disposed/sold 89,545 options to buy @ $14.77, valued at $1.3M
Disposed/sold 60,000 options to buy @ $15.14, valued at $908.4k
Disposed/sold 21,500 options to buy @ $17.59, valued at $378.2k
Disposed/sold 100,000 options to buy @ $12.9, valued at $1.3M
Disposed/sold 104,000 options to buy @ $25.27, valued at $2.6M
Disposed/sold 10,152 restricted stock units @ $0
Disposed/sold 6,802 restricted stock units @ $0
Disposed/sold 16,667 restricted stock units @ $0
08/11/2023 4 GRIFFIN MICHELLE RENEE (Director) has filed a Form 4 on CHINOOK THERAPEUTICS, INC.
Txns: Disposed/sold 3,300 shares @ $0
Disposed/sold 23,522 options to buy @ $14.77, valued at $347.4k
Disposed/sold 5,948 options to buy @ $16.81, valued at $100k
Disposed/sold 13,300 options to buy @ $13.88, valued at $184.6k
08/11/2023 4 Greenman William Mariner (Director) has filed a Form 4 on CHINOOK THERAPEUTICS, INC.
Txns: Disposed/sold 23,643 shares @ $0
Disposed/sold 3,600 options to buy @ $5, valued at $18k
Disposed/sold 8,000 options to buy @ $85, valued at $680k
Disposed/sold 2,600 options to buy @ $62.1, valued at $161.5k
Disposed/sold 2,600 options to buy @ $52.75, valued at $137.2k
Disposed/sold 4,000 options to buy @ $33, valued at $132k
Disposed/sold 6,000 options to buy @ $16.45, valued at $98.7k
Disposed/sold 6,000 options to buy @ $15, valued at $90k
Disposed/sold 23,522 options to buy @ $14.77, valued at $347.4k
Disposed/sold 5,948 options to buy @ $16.81, valued at $100k
Disposed/sold 13,300 options to buy @ $13.88, valued at $184.6k
08/11/2023 4 Frohlich Tom (COO) has filed a Form 4 on CHINOOK THERAPEUTICS, INC.
Txns: Disposed/sold 150,777 shares @ $0
Disposed/sold 43,847 options to buy @ $0.42, valued at $18.4k
Disposed/sold 119,793 options to buy @ $14.77, valued at $1.8M
Disposed/sold 60,000 options to buy @ $15.14, valued at $908.4k
Disposed/sold 30,000 options to buy @ $17.59, valued at $527.7k
Disposed/sold 100,000 options to buy @ $12.9, valued at $1.3M
Disposed/sold 84,000 options to buy @ $25.27, valued at $2.1M
Disposed/sold 13,581 restricted stock units @ $0
Disposed/sold 6,801 restricted stock units @ $0
Disposed/sold 16,667 restricted stock units @ $0
Disposed/sold 21,000 restricted stock units @ $0
08/11/2023 4 DOBMEIER ERIC (President, CEO) has filed a Form 4 on CHINOOK THERAPEUTICS, INC.
Txns: Disposed/sold 301,138 shares @ $0
Disposed/sold 353,358 options to buy @ $0.35, valued at $123.7k
Disposed/sold 313,555 options to buy @ $0.42, valued at $131.7k
Disposed/sold 271,647 options to buy @ $14.77, valued at $4M
Disposed/sold 178,600 options to buy @ $15.14, valued at $2.7M
Disposed/sold 300,000 options to buy @ $12.9, valued at $3.9M
Disposed/sold 255,150 options to buy @ $25.27, valued at $6.4M
Disposed/sold 30,797 restricted stock units @ $0
Disposed/sold 20,248 restricted stock units @ $0
Disposed/sold 50,001 restricted stock units @ $0
Disposed/sold 64,050 restricted stock units @ $0
08/11/2023 4 Jerel Davis (Director) has filed a Form 4 on CHINOOK THERAPEUTICS, INC.
Txns: Disposed/sold 447,013 shares @ $0
Disposed/sold 2,105,107 shares @ $0
Disposed/sold 719,104 shares @ $0
Disposed/sold 210,996 shares @ $0
Disposed/sold 23,522 options to buy @ $14.77, valued at $347.4k
Disposed/sold 5,948 options to buy @ $16.81, valued at $100k
Disposed/sold 13,300 options to buy @ $13.88, valued at $184.6k
08/11/2023 4 BJERKHOLT ERIC (CFO) has filed a Form 4 on CHINOOK THERAPEUTICS, INC.
Txns: Disposed/sold 39,371 shares @ $0
Disposed/sold 144,787 options to buy @ $13.98, valued at $2M
Disposed/sold 21,501 options to buy @ $15.14, valued at $325.5k
Disposed/sold 88,000 options to buy @ $12.9, valued at $1.1M
Disposed/sold 84,000 options to buy @ $25.27, valued at $2.1M
Disposed/sold 16,415 restricted stock units @ $0
Disposed/sold 2,435 restricted stock units @ $0
Disposed/sold 14,667 restricted stock units @ $0
Disposed/sold 21,000 restricted stock units @ $0
Disposed/sold 8,400 restricted stock units @ $0
08/11/2023 4 Azelby Robert (Director) has filed a Form 4 on CHINOOK THERAPEUTICS, INC.
Txns: Disposed/sold 28,200 options to buy @ $21.6, valued at $609.1k
Disposed/sold 7,000 restricted stock units @ $0
08/11/2023 4 AKKARAJU SRINIVAS (Director) has filed a Form 4 on CHINOOK THERAPEUTICS, INC.
Txns: Disposed/sold 3,300 shares @ $0
Disposed/sold 5,161,888 shares @ $0
Disposed/sold 23,522 options to buy @ $14.77, valued at $347.4k
Disposed/sold 5,948 options to buy @ $16.81, valued at $100k
Disposed/sold 13,300 options to buy @ $13.88, valued at $184.6k
08/11/2023 25-NSE Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities:
08/07/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/03/2023 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
08/01/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/01/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy